阿克他利治疗类风湿关节炎患者的临床疗效  

The Clinical Efficacy of Actarit in Treatment of Rheumatoid Arthritis

作　　者：王济远 

机构地区：[1]武警德宏边防支队医院,云南德宏678400

出　　处：《中国药物经济学》2015年第10期36-38,共3页China Journal of Pharmaceutical Economics

摘　　要：目的探讨阿克他利治疗类风湿关节炎患者的临床疗效。方法选取2013年7月至2014年6月武警德宏边防支队医院收治的类风湿关节炎患者资料70例,按随机数字表法将其分为对照组和观察组,各35例。对照组患者口服甲氨蝶呤片,观察组患者采用阿克他利治疗。比较两组患者的临床疗效。结果观察组患者总有效率为94.3%,明显高于对照组的77.1%,差异有统计学意义(P<0.05);治疗后两组患者各项症状指标均明显改善,差异均有统计学意义(均P<0.05);观察组患者的不良反应发生率为8.6%,明显低于对照组的31.4%,差异有统计学意义(P<0.05)。结论应用阿克他利治疗类风湿关节炎患者临床疗效明显,不良反应少。Objective To investigate the clinical efficacy of actarit in treatment of rheumatoid arthritis.Methods From July 2014 to June 2013, 70 patients with rheumatoid arthritis were randomly divided into control group and observation group by random number table method,35 cases in each group.The control group were treated with Methotrexate Tablets,observation group were treated by treatment of actarit.To compare the clinical efficacy of the two groups of patients.Results Difference was statistically significant in the observation group,the total efficiency of 94.3%,which was significantly higher than that in the control group 77.1%;two groups of patients with various symptoms index were significantly improved after treatment,differences were statistically significant（P〈0.05）; observation group of patients with adverse reaction rate was 8.6%,significantly lower than the control group of 31.4%,the difference is statistically significant（P〈0.05）.Conclusion Clinical application of actarit in treatment of rheumatoid arthritis significantly,less adverse reaction.

关 键 词：类风湿关节炎 阿克他利 临床疗效 不良反应 

分 类 号：R593.22[医药卫生—内科学]